Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Telmisartan/Amlodipine and Rosuvastatin in Hypertension and Hyperlipidemia
NCT03067688Phase 3Completed
- Sponsor
- Yuhan
- Start
- Apr 2017
- Primary completion
- Mar 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of telmisartan, amlodipine, rosuvastatin in hypertension (HTN), hyperlipidemia, sponsored by Yuhan. Started Apr 2017; status: completed.
02
Drugs
telmisartanamlodipinerosuvastatin
03
Conditions
hypertension (HTN)hyperlipidemia
Beyond the preview
Go deeper on NCT03067688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03067688.